Pearls & Oy-sters: Relapse of anti-NMDA receptor encephalitis after prior first- and second-line immunotherapy

Neurology. 2018 May 15;90(20):936-939. doi: 10.1212/WNL.0000000000005517.

Authors

Sharon Chiang¹, Tanu Garg¹, Austin Hu¹, Hitha Amin¹, Alfredo Davalos-Balderas¹, Isabel Alfradique-Dunham¹, Corey E Goldsmith²

Affiliations

¹ From the School of Medicine (S.C.), Department of Neurology (T.G., H.A., A.D.-B., I.A.-D., C.E.G.), and Department of Internal Medicine (A.H.), Baylor College of Medicine, Houston, TX.
² From the School of Medicine (S.C.), Department of Neurology (T.G., H.A., A.D.-B., I.A.-D., C.E.G.), and Department of Internal Medicine (A.H.), Baylor College of Medicine, Houston, TX. [email protected].

PMID: 29759996
DOI: 10.1212/WNL.0000000000005517

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnostic imaging
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / physiopathology
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / therapy*
Electroencephalography
Female
Humans
Immunologic Factors / therapeutic use*
Immunotherapy / methods*
Magnetic Resonance Imaging
Recurrence

Substances

Immunologic Factors